Abstract
AbstractObjectiveHepatitis B virus (HBV) and hepatitis C virus (HCV) are prevalent in West Africa. To address the WHO 2030 goals of a 90% reduction in incidence and a 65% reduction in mortality for both infections, we assessed the prevalence of HBV and HCV from surveys in the general population.MethodsParticipants in this cross‐sectional survey were included from randomly selected houses in a demographic surveillance site in Bissau, Guinea‐Bissau. Participants were interviewed and had a blood sample drawn for viral analyses (HBsAg, anti‐HBs, anti‐HBc, anti‐HCV and HCV RNA). Risk factors of HBV and HCV infection were determined by binomial regression adjusted for sex and age.ResultsA total of 2715 participants were included in this study. The overall HBsAg prevalence was 18.7% (95% CI: 17.3–20.2%). HBsAg was associated with male sex (adjusted risk ratio (aRR): 1.64), and prevalence decreased with age >34 years. HBV exposure was found in 91.9% of participants. Although 72.6% of individuals without sexual debut had been exposed to HBV, ever engaging in a sexual relationship was associated with higher risk of HBV exposure (aRR 1.18). The anti‐HCV prevalence was 0.5% (95% CI: 0.3–0.9%), and 78.6% of those had detectable HCV RNA. Risk factors for anti‐HCV sero‐positivity were age above 55 (aRR 10.60), a history of blood transfusion (aRR 5.07) and being in a polygamous marriage (aRR 3.52).ConclusionIn Guinea‐Bissau initiatives to implement treatment and widespread testing are needed to reach the WHO 2030 goals.
Topics

No keywords indexed for this article. Browse by subject →

References
56
[33]
Mamadou S "HIV infection and hepatitis B seroprevalence among antenatal clinic attendees in Niger, West Africa" HIVAIDS Auckl NZ (2012)
[38]
Ndow G "Hepatitis B testing and treatment in HIV patients in The Gambia‐Compliance with international guidelines and clinical outcomes" PLoS ONE One (2017) 10.1371/journal.pone.0179025
[39]
Archampong TNA "Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co‐infected Ghanaian patients" BMC Infect Dis (2016)
[40]
Tremeau‐Bravard A "Seroprevalence of hepatitis B and C infection among the HIV‐positive population in Abuja, Nigeria" African Health Sciences (2012)
[43]
World hepatitis day in Burkina Faso, 2017: seroprevalence and vaccination against hepatitis B virus to achieve the 2030 elimination goal

Birama Diarra, Albert Théophane Yonli, Abdoul Karim Ouattara et al.

Virology Journal 10.1186/s12985-018-1032-5

Showing 50 of 56 references

Metrics
13
Citations
56
References
Details
Published
Nov 20, 2019
Vol/Issue
25(2)
Pages
255-263
License
View
Authors
Funding
Aase og Ejnar Danielsens Fond
Cite This Article
Bo Langhoff Hønge, Jens Steen Olesen, Mads Mose Jensen, et al. (2019). Hepatitis B and C in the adult population of Bissau, Guinea‐Bissau: a cross‐sectional survey. Tropical Medicine & International Health, 25(2), 255-263. https://doi.org/10.1111/tmi.13335